JASON HENDERSON, D.O., J.D.

**** ****** *** ***** ***** 317-***-**** (CELL)

INDIANAPOLIS, INDIANA 46254 acefpa@r.postjobfree.com

OBJECTIVE

Board certified internal medicine physician with additional expertise in law, global health, FDA compliance and

regulations, and pharmacovigilance who is seeking the ability to work alongside respected colleagues in a global

healthcare economy to improve the delivery and efficiency of healthcare outcomes.

EDUCATION

Doctor of Jurisprudence (J.D.) Indiana University Maurer School of Law (2011)

Bloomington, IN

Internal Medicine Residency University of Connecticut (2002)

Harford, CT

Doctor of Osteopathic Medicine (D.O.) Philadelphia College of Osteopathic Medicine, D.O. (1999)

Philadelphia, PA

Bachelor of Arts (B.A.) Saint Anselm College (1995)

Manchester, NH

PROFESSIONAL EXPERIENCE

2011 – Present HERO Network, LLC Telecommute

Director of Research & Medical Affairs Liaison

• Work with a Team of independent contractors who consult on program development, grant funding

acquisitions, and management of research initiatives while also serving an investigator on collaborative research

initiatives.

• Independent and consulting pharmacovigilance physician and medical monitor for Phase II–IV clinical

trials.

• Performs expert regulatory analysis and compliance services as needed for clients.

• Industry experience as an external-facing Medical Affairs/ Advisory role

2012 – February 2013 Technical Resources International, Inc. Bethesda, MD

Safety & Pharmacovigilance Physician/ Medical Monitor

• Evaluated and processed Serious Adverse Event (SAE) reports received from clinical sites on four

continents including preparation of Safety Reports as per project and regulatory guidelines.

• Collected accurate information from the site as required per the project and also responded to site queries.

• Provided medical evaluation of serious adverse event reports.

• Independently reviewed experimental protocols and safety information from the NIH Division of

Microbiology and Infectious Diseases (DMID)-held and non-DMID-held Investigational New Drug application

(IND) studies.

• Analyzed medical research data to summarize safety data into chronologically, well thought out, and

detailed expedited safety reports.

• Responded to e-mail or phone queries from sites and DMID Medical Monitors regarding standard

processes and case specific issues.

• Researched clinical and regulatory complexities associated with investigational studies and proposed

appropriate solutions.

• Participated in the development of new Project Work Instructions (PWI’s), Project Specific Procedure

(PSP’s), and Standard Operating Procedures (SOP’s) when appropriate to update previously developed project

procedures for improved compliance and efficiency.

• Actively participated in client meetings as necessary and appropriate.

2

2012 The National Academy of Sciences, Institute of Medicine Washington, D.C.

Post- Doctoral Fellow

• Assigned to the Institute of Medicine’s Board of Global Health.

• Researched the global public health impact of counterfeit, falsified, and sub-standard medications.

• Developed health policy proposals and recommendations for presentation to key policy leaders.

• Supervisor: Patrick Kelley, M.D., Dr.PH.

2010 – 2011 Brown Law Firm, PC Indianapolis, IN

Medical-Legal Consultant

• Acted as a medical-legal consultant on multiple medical and pharmaceutical negligence lawsuits.

2009 – 2010 Carson Boxberger, LLP Bloomington, IN

Litigation Support (Law Clerk)

• Participated, researched, and prepared documents for all levels of civil litigation with special emphasis on

physician malpractice defense and tort law.

2005 – 2008 Maine General Medical Center Augusta, ME

Hospitalist Physician

• Admitted and treated patients in the medical, surgical, and intensive care units.

• Provided medical consults to surgical, hospice, and psychiatric patients.

• Heavily involved with the medical training of externs, interns, and residents.

SPECIALIZED TRAINING & PROFESSIONAL DEVELOPMENT

Board Certified Diplomat, American Osteopathic Board of Internal Medicine (2005)

National Institutes of Health Information Security Awareness (2012)

National Institutes of Health Plain Language Training (2012)

FDA Inspection Self-Guided Training (2012)

The Protection of Human Research Subjects – Good Clinical Practice CITI course (2012)

The Protection of Human Research Subjects – Track 1 (biomedical) CITI course (2012)

SPECIALIZED SKILLS

International & Social Science Research:

• Comprehensive literature review capabilities focusing on conceptual, historical, clinical, epidemiological, ethical,

regulatory, or similar aspects of an issue.

• Understanding of the history and development of key international institutions, pivotal policies, and theoretical

frameworks informing international bioethics and research ethics, case studies of specific areas in international

bioethics.

• The ability to identify and explain the prominent ethical, social, and legal issues in research ethics and apply

ethical and professional principles to those issues.

• Individual case analysis: making informed and reasoned judgments about the proper conduct of research and can

design and develop a plan to promote education in, and professional awareness of research ethics, and the

responsible conduct of research.

Medical Science & Affairs:

• Ability to communicate complex cutting-edge scientific information and research concepts to healthcare decision

makers including those at Academic Medical Centers.

• Providing clinical and economic value information to payers and formulary decision makers.

Jason Henderson, D.O., J.D. CV

3

• Provide medical and scientific expertise to other departments, and act as a representative at specific continuing-

education events/programs, medical meetings and conventions.

• Capability to represent a Client and its marketed product on a peer-to-peer level, engaging in clinically-based

exchanges with national, regional and local key leaders and tertiary audiences (including Managed Care

Organizations, Pharmaceuticals and Therapeutics, and Committees and Payers).

Medical Monitoring and Drug Safety:

• Proficient review of laboratory values, adverse events, coding dictionaries and data tables, listings and figures,

etc. to identify drug safety issues in collaboration with the project physician.

• Ability to maintain responsibility for medical review of serious adverse events and non-serious adverse events

from spontaneous reports, reports derived from regulatory authorities and current medical literature during post-

marketing surveillance in support of drug safety activities for clients.

• Substantial knowledge of pharmacovigilance and the global regulations governing drugs, biologics, & device

safety activities both during clinical development and during the post-marketing phase of lifecycle management.

AWARDS/HONORS

Myzrian Science Policy Post-Doctoral Fellowship Recipient, National Academies of Science (2012)

Academic Scholarship Recipient, Indiana University Maurer School of Law (2008-2011)

Chief Fellow of Geriatrics, University of Medicine and Dentistry of New Jersey (2006)

American Geriatric Society Elected Board Member, National Ethics Committee (2005)

“Medical Intern of the Year” Award, University of Connecticut Health Center (1999)

Summa cum laude, Saint Anselm College (1995)

SELECTED PROFESSIONAL AFFILIATIONS

The Network for Public Health Law, Member, 2012– Present

American Board of Legal Medicine, 2010– Present

American Geriatric Society, 2004– Present

American College of Physicians, 2004– Present

SELECTED PUBLICATIONS & PRESENTATIONS

Mullins-Owens HL, Henderson, ML., Henderson, J. (2012 ) Protecting a Vulnerable Population with Little Regulatory

Framework: A Comparative Analysis of International Guidelines for Pediatric Research Ethics . Journal of Contemporary

Health Law and Policy. Volume 29(1): Fall 2012.

Editorial Supervisor, Indiana Continuing Legal Education. Business Law Essentials LLCs, Mergers, and Acquisitions .

Presented November, 2012.

Risk Shifting and Healthcare Reform, Power Point presentation to key health insurance stakeholders. April, 2013.

Jason Henderson, D.O., J.D. CV

Contact this candidate